Anti-Adalimumab Antibodies (Free)

Description
The measurement of anti-Adalimumab antibodies enables a greater understanding as to the underlying aetiology of treatment failure. Patients with detectable anti-Adalimumab antibodies may be at risk of developing hypersensitivity reactions, particularly those being re-introduced after drug interruption. The detection of anti-Adalimumab antibodies also guides management decisions on concomitant immunosupression , dose escalation, drug switching and withdrawal. Measured as part of a profile including Adalimumab levels.
Clinical details

Due to the structure of the anti-TNFα drugs, the immune system may stimulate formation of antibodies against the drug (ADA, anti-drug antibodies). Antibody formation is associated with allergic reactions and loss of response due to neutralisation of biological effect and/or increased clearance of drug. Adalimumab, being a fully humanised monoclonal antibody, is thought to be less immunogenic than Infliximab.

Related condition
Reference range

<10 ng/mL Please note that in the presence of drug, anti-drug antibody may not be detected. Test interpretation requires full clinical information: drug dosage/frequency, previous exposure to other biologics, time of sampling, duration of therapy and clinical assessment.

Units

ng/mL

Testing site
Synnovis : Reference Services : Blackfriars Hub
Laboratory
Precision Medicine
Sample type and volume required

Serum (SST tube or plain) sample is preferred. Plasma (Lithium heparin, citrate or EDTA) is also acceptable. Minimum 300μL serum or plasma required for both drug and anti-drug antibody analysis.

Special sample instructions

Collect blood into a serum separation (SST™) or plain tube, preferably shortly before drug administration (trough levels). Centrifuge sample at 3000 rpm for 10 minutes, aliquot serum or plasma and keep in fridge until transport. If transport is going to be delayed by > 5 days, freeze at -20°C and send by first class post at a later date.

Anti-TNF User Information

Storage and transport

Post the sample to Synnovis Central Specimen Reception by first class post (see request form for full address).

Anti-TNF Alpha Drugs Request Form

Turnaround time

2 weeks

Contacts

Precision Medicine Laboratory at Blackfriars Hub
Phone: 020 4 591 0058
Reference Chemistry
Floor 1, Synnovis hub
Friars Bridge Court
41-43 Blackfriars Road
London
SE1 8NZ

Last updated:

Back to search